A One-Week Crossover Dispensing Evaluation of New Daily Wear Soft Contact Lenses
- Conditions
- Myopia
- Interventions
- Device: Test Contact LensDevice: Nelfilcon A
- Registration Number
- NCT03306641
- Lead Sponsor
- Coopervision, Inc.
- Brief Summary
The purpose of this study is to validate the clinical performance of a new contact lens design when worn over a period 1 week compared to nelfilcon A (control).
- Detailed Description
The purpose of this study is to validate the clinical performance of a new contact lens design when worn over a period of 1 week compared to nelfilcon A (control). The primary outcomes of interest is lens fit acceptance.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 45
- Is at least 18 years of age and has full legal capacity to volunteer.
- Is no greater than 55 years of age.
- Has read and understood the information consent letter.
- Is willing and able to follow instructions and maintain the appointment schedule.
- Is an adapted soft contact lens wearer having worn lenses for a minimum of 4 weeks prior to the study.
- Has spectacle cylinder ≤1.00D in both eyes.
- Has spherical contact lens power requirement between -1.00D and -6.00D in both eyes.
- Has manifest refraction visual acuities (VA) equal to or better than logMAR equivalent of 20/25 in each eye.
- Wears CLs in both eyes (monvision acceptable, but not monofit)
- Has clear corneas and no active ocular disease.
- Has not worn lenses for at least 12 hours before the examination.
- Is willing to wear the study contact lenses for a minimum 8 hours per day/6 days per week
- Has never worn contact lenses before.
- Has any systemic disease affecting ocular health.
- Is using any systemic or topical medications that will affect ocular health.
- Has any ocular pathology or severe insufficiency of lacrimal secretion (moderate to severe dry eyes) that would affect the wearing of contact lenses.
- Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye.
- Has any clinically significant lid or conjunctival abnormalities, active neovascularization or any central corneal scars.
- Is aphakic.
- Has strabismus/amblyopia.
- Has undergone corneal refractive surgery.
- Is pregnant, lactating or planning a pregnancy.
- Is participating in any concurrent clinical or research study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Test Contact Lens Nelfilcon A Per randomized schedule, subject will wear a pair of the test lens or control lens for one week and then cross-over with the control pair for 1 week. nelfilcon A lens (control) Nelfilcon A Per randomized schedule, subject will wear a pair of the control lens for one week and then cross-over with the test pair for 1 week. Test Contact Lens Test Contact Lens Per randomized schedule, subject will wear a pair of the test lens or control lens for one week and then cross-over with the control pair for 1 week. nelfilcon A lens (control) Test Contact Lens Per randomized schedule, subject will wear a pair of the control lens for one week and then cross-over with the test pair for 1 week.
- Primary Outcome Measures
Name Time Method Lens Fit Acceptance 1-Week Overall lens fit acceptance was measured on a scale of 0-4 in 0.25 steps (0=can't be worn, 1=Poor, 2=Fair, 3=Good, 4=Optimum)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Clinical Optics Research Lab (CORL) Indiana University School of Optometry, Indiana University
🇺🇸Bloomington, Indiana, United States